期刊文献+

血管内皮生长因子对胃癌BGC-823细胞多药耐药相关蛋白1启动子活性的影响

Effect of vascular endothelial growth factor on the activity of multidrug resistance-associated protein 1 promoter in gastric cancer cell line BGC-823
下载PDF
导出
摘要 目的:检测血管内皮生长因子(VEGF)对多药耐药相关蛋白1(MRP1)基因启动子转录活性的影响并初步探讨其作用机制。方法:合成MRP1启动子片段,克隆到荧光素酶报告基因载体PGL3-Basic中;用脂质体2000将重组的报告基因载体与内参质粒β-半乳糖苷酶(β-gal)瞬时共同转染人胃癌BGC-823细胞,检测VEGF作用后MRP1启动子活性的改变;继之,采用PI3K/AKT信号通路抑制剂LY294002预处理转染的细胞,再检测VEGF对MRP1启动子转录活性的影响。结果:酶切鉴定和DNA序列分析表明成功地构建了重组PGL3-Basic-MRP1载体;荧光素酶活性分析表明重组PGL3-Basic-MRP1在BGC-823细胞中具有启动子活性(144±3.0),与空载体PGL3-Basic(60±4.910)相比,转录活性增高2.4倍,差异有统计学意义(P<0.01);VEGF能以剂量依赖的方式上调MRP1启动子区的转录活性,与无VEGF作用组(171±6.083)相比,最大活性(924±19.975)增高5.4倍(P<0.05);LY294002能够显著抑制VEGF对MRP1启动子区的转录激活,当LY294002浓度为50μmol/ml时,MRP1启动子活性(392±25.541)与无LY294002作用组(1001±11.533)相比下降2.5倍(P<0.05)。结论:VEGF对MRP1启动子活性具有上调作用,PI3K/AKT信号通路在这一过程中发挥了重要作用。 Objective:To assess the efficacy and mechanism of vascular endothelial growth factor(VEGF) on the transcriptional activity of the the multidrug resistance-associated protein 1(MRP1) promoter.Methods:The promoter of MRP1 was synthesized and cloned into the luciferase reporter gene vector PGL3-Basic.The recombinant plasmid was transiently co-transfected into BGC-823 cells with control vector β-gal by lipofectamine 2000 reagent,and then detected the alteration of the MRP1 promoter activity after being treated with VEGF.Subsequently,pretreated co-transfected cells with PI3K/AKT signaling pathway inhibitor LY294002,and then evaluated the effect of VEGF on the MRP1 promoter activity.Results:The consequence of restriction enzyme digestion and nucleotide sequence analysis confirmed that the recombinant plasmid was successfully constructed.The analysis of the luciferase reporter gene activity demonstrated that the recombinant plasmid displayed marked activity(144±3.0) in BGC-823 cells,about 2.4-fold than that seen with control vector PGL3-Basic(60±4.910,P0.01).Importantly,this activity was up-regulated by VEGF in a dose-dependent manner,and the most pronounced activity(924±19.975) was at least 5.4-fold above that when cells cultured without VEGF(171±6.083,P0.05);Furthermore,LY294002 significantly supressed the effect of VEGF on the MRP1 promoter activity.Compared with cells cultured in the Absence of LY294002(1 001±11.533),the activity of the MRP1 promoter was reduced 2.5-fold when cells were exposured to 50 μmol/ml LY294002 (392±25.541) (P0.05).Conclusion:VEGF could augment the activity of the MRP1 promoter,and PI3K/AKT signaling pathway was proposed to be a critical factor underlying this mechanism of action.
出处 《江苏大学学报(医学版)》 CAS 2010年第2期121-125,共5页 Journal of Jiangsu University:Medicine Edition
基金 江苏省卫生重大课题基金资助项目(K2005017)
关键词 多药耐药相关蛋白1 血管内皮生长因子 荧光素酶报告基因 启动子活性 multidrug resistance-associated protein 1 vascular endothelial growth factor luciferase reporter gene promoter activity
  • 相关文献

参考文献11

  • 1许文林,沈慧玲,袁伟,江云伟,吴朝阳,费霞,唐华容.K562细胞血管内皮生长因子自分泌链作用的实验研究[J].中华血液学杂志,2007,28(3):189-193. 被引量:6
  • 2Zhu Q,Center MS.Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin[J].Cancer Res,1994,54(16):4488-4492.
  • 3Altenberg GA.Structure of multidrug-resistance proteins of the ATP-binding cassette(ABC)superfamily[J].Curr Med Chem Anticancer Agents,2004,4(1):53-62.
  • 4Laupeze B,Amiot L,Drenou B,et al.High multidrug resistance protein activity in myeloid leukemias is associated with poor response to chemotherapy and reduced patient survival[J].Br J Haematol,2002,116(4):834-838.
  • 5Ferrara N,Henzel WJ.Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells[J].Biochem Biophys Res Commun,1989,161(2):851-858.
  • 6Santos SC,Dias S.Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways[J].Blood,2004,103(10):3883-3889.
  • 7Tazzari PL,Cappellini A,Ricci F,et al.Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts[J].Leukemia,2007,21 (3):427-438.
  • 8Volm M,Rittgen W.Cellular predictive factors for the drug response of lung cancer[J].Anticancer Res,2000,20(5B):3449-3458.
  • 9Amino N,Ideyama Y,Yamano M,et al.YM-359445,an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor,has highly potent antitumor activity against established tumors[J].Clin Cancer Res,2006,12(5):1630-1638.
  • 10Zhang XS,Zhu XF,Gao JS,et al.Multiple drug resistance phenotype of human endothelial cells induced by vascular endothelial growth factor 165[J].Acta Pharmacol Sin,2001,22(8):731-735.

二级参考文献12

  • 1许文林,沈慧玲,袁伟,王法春,江云伟.抗血管内皮生长因子发夹状核酶基因抑制白血病细胞裸鼠体内生长和肿瘤内血管生成[J].中华血液学杂志,2006,27(7):465-469. 被引量:2
  • 2de Bont ES, Fidler V, Meeuwsen T, et al. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. Clin Cancer Res,2002,8:2856-2861.
  • 3Verstovsek S, Lunin S, Kantarjian H, et al. Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia. Leuk Res,2003, 27:661-669.
  • 4Zogakis TG, Libutti SK. General aspects of anti-angiogenesis and cancer therapy. Expert Opin Biol Ther,2001,1:253-275.
  • 5O' Neill B, Millington-Ward S, O' Reilly M, et al. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.Invest Ophthalmol Vis Sci, 2000, 41:2863-2869.
  • 6Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood,2000,96:2240-2245.
  • 7Charnock-Jones DS, Sharkey AM, Boocock CA, et al. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod, 1994,51 : 524-530.
  • 8Bellamy WT, Richter L, Siijani D, et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood ,2001, 97 : 1427-1434.
  • 9Ratajczak MZ, Ratajczak J, Machalinski B, et al. Role of vascular endothelial growth factor and placenta-derived growth factor in regulating human haemopoietic cell growth. Br J Haematol, 1998,103:969-979.
  • 10Rossi JJ. Controlled, targeted, intracellular expression of ribozymes: progress and problems. Trends Biotechnol, 1995, 13 :301-306.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部